FCER2 and B-cell chronic lymphocytic leukemia: Flow cytometry, the diagnostic cornerstone in CLL, has been enhanced by AI models capable of predicting the necessity for extended antibody panels (e.g., CD23, FMC-7, and CD200) with real-time inference.